[ET Net News Agency, 10 March 2026] ASCENTAGE-B (06855) rose 9.4% to HK$47.72.
It hits an intra-day high of HK$47.96, breaking above the 20-D SMA of HK$46.346, and an intra-day low of HK$43.92. The total shares traded was 1.26 million, with a value of HK$58.34m. The active buy/sell ratio is 73:27, with net buying turnover of HK$25.93m. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive buying turnover of HK$564,335, with volume weighted average price of HK$46.013. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$3.75m, with volume weighted average price of HK$46.26.
Basic Information| Nominal | 47.720 | % Chg | +9.45% |
| High | 47.960 | Low | 43.920 |
| Shares Tr | 1.26m | Turnover | 58.34m |
| 10-D SMA | 45.286 | %H.V | 44.479 |
| 20-D SMA | 46.346 | VWAP | 46.466 |
| 50-D SMA | 49.247 | RSI14 | 51.838 |
Status: Breaking above the 20-D SMA, active buy/sell ratio is 73:27, with net buying turnover of HK$25.93m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| ASCENTAGE-B (06855) | 47.72 | +9.45 |
| INNOVENT BIO (01801) | 85.45 | +4.53 |
| CARSGEN-B (02171) | 15.46 | +11.06 |
| XTALPI (02228) | 9.93 | +1.95 |
| WUXI BIO (02269) | 36.36 | +2.65 |
| WUXI APPTEC (02359) | 110.90 | +1.93 |
| TRANSTHERA-B (02617) | 84.25 | -1.52 |
| BEONE MEDICINES (06160) | 184.40 | +3.07 |
| AKESO (09926) | 114.00 | +9.93 |
| REMEGEN (09995) | 89.10 | +4.39 |
(ed)
